OBJECTIVES: This study aims to review the current state of spinal cord stimulation for the treatment of chronic pain associated with failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS) and to describe intraspinal targets and stimulation parameters, patient selection, therapy cost-effectiveness, and strategies to improve outcomes. MATERIALS AND METHODS: We drew on professional literature spanning four decades, our work with national and international professional societies, and our own extensive clinical experience to summarize contemporary knowledge of the safety, efficacy, cost-efficiency, and challenges associated with spinal cord stimulation in treating chronic pain. RESULTS: The safety, efficacy, and cost-efficiency of spinal cord stimulation in treating chronic pain associated with FBSS and CRPS are well established through randomized controlled trials and long-term observational studies. Challenges include reducing wait-times before implant, which are associated with lower success rates; increasing awareness of this therapy among referring physicians, patients, and payers; decreasing device-related complications by incorporating advanced technology, improved operative and trialing techniques, and appropriate patient selection; and capturing functional and quality-of-life outcomes. Spinal cord stimulation must be part of an overall treatment plan to manage chronic pain, and must engage physicians, patients, their families, pharmacists, nursing staff, and mental health experts in supporting a return to employment, if possible, and to a full domestic and social life. CONCLUSIONS: Innovation in spinal cord stimulation therapy has intensified with numerous new technical capabilities, safety advances, and novel stimulation targets. This progress holds hope for the many sufferers of chronic pain.
OBJECTIVES: This study aims to review the current state of spinal cord stimulation for the treatment of chronic pain associated with failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS) and to describe intraspinal targets and stimulation parameters, patient selection, therapy cost-effectiveness, and strategies to improve outcomes. MATERIALS AND METHODS: We drew on professional literature spanning four decades, our work with national and international professional societies, and our own extensive clinical experience to summarize contemporary knowledge of the safety, efficacy, cost-efficiency, and challenges associated with spinal cord stimulation in treating chronic pain. RESULTS: The safety, efficacy, and cost-efficiency of spinal cord stimulation in treating chronic pain associated with FBSS and CRPS are well established through randomized controlled trials and long-term observational studies. Challenges include reducing wait-times before implant, which are associated with lower success rates; increasing awareness of this therapy among referring physicians, patients, and payers; decreasing device-related complications by incorporating advanced technology, improved operative and trialing techniques, and appropriate patient selection; and capturing functional and quality-of-life outcomes. Spinal cord stimulation must be part of an overall treatment plan to manage chronic pain, and must engage physicians, patients, their families, pharmacists, nursing staff, and mental health experts in supporting a return to employment, if possible, and to a full domestic and social life. CONCLUSIONS: Innovation in spinal cord stimulation therapy has intensified with numerous new technical capabilities, safety advances, and novel stimulation targets. This progress holds hope for the many sufferers of chronic pain.
Authors: Ajay B Antony; B Carsten Schultheis; Suneil M Jolly; Daniel Bates; Corey W Hunter; Robert M Levy Journal: Pain Med Date: 2019-06-01 Impact factor: 3.750
Authors: Muhammad M Edhi; Lonne Heijmans; Kevin N Vanent; Kiernan Bloye; Amanda Baanante; Ki-Soo Jeong; Jason Leung; Changfang Zhu; Rosana Esteller; Carl Y Saab Journal: Sci Rep Date: 2020-11-23 Impact factor: 4.379
Authors: Yan Han; Yang Lu; Dengyu Wang; Mingshan Ran; Qidong Ren; Duo Xie; Tipu Z Aziz; Luming Li; James Jin Wang Journal: Neuromodulation Date: 2021-03-22
Authors: Timothy R Deer; Robert M Levy; Jeffery Kramer; Lawrence Poree; Kasra Amirdelfan; Eric Grigsby; Peter Staats; Allen W Burton; Abram H Burgher; Jon Obray; James Scowcroft; Stan Golovac; Leonardo Kapural; Richard Paicius; Christopher Kim; Jason Pope; Thomas Yearwood; Sam Samuel; W Porter McRoberts; Hazmer Cassim; Mark Netherton; Nathan Miller; Michael Schaufele; Edward Tavel; Timothy Davis; Kristina Davis; Linda Johnson; Nagy Mekhail Journal: Pain Date: 2017-04 Impact factor: 7.926
Authors: Erich Talamoni Fonoff; Andrea C de Lima-Pardini; Daniel Boari Coelho; Bernardo Assumpção Monaco; Birajara Machado; Carolina Pinto de Souza; Maria Gabriela Dos Santos Ghilardi; Clement Hamani Journal: Front Neurol Date: 2019-08-27 Impact factor: 4.003